2 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Vascular Disorder: new trials by email Literature Review of Vascular Disorder trials Research Report on Vascular Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma KLN-1010 - Multiple Myeloma in Relapse, Myeloma Multiple | Phase 1 | Recruiting | Kelonia Therapeutics, Inc. | 70 | 2025-07-16 | 2026-08-28 |
| Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care Anti-Cancer Agents - Cardiovascular Complication, Cardiovascular Insufficiency | Recruiting | Groupe Hospitalier Pitie-Salpetriere | 5000 | 2019-03-01 | 2026-09-11 |
Vascular Diseases (2) · Blood Protein Disorders (1) · Cardiotoxicity (1) · Disease (1) · Drug-Related Side Effects and Adverse Reactions (1) · Heart Diseases (1) · Heart Failure (1) · Hematologic Diseases (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Metabolic Diseases (1) · Multiple Myeloma (1) · Neoplasms (1)
Cardiovascular Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Chemically-Induced Disorders (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Lymphatic Diseases (1) · Neoplasms, Plasma Cell (1) · Nutritional and Metabolic Diseases (1) · Radiation Injuries (1) · Wounds and Injuries (1)
Groupe Hospitalier Pitie-Salpetriere (1) · Kelonia Therapeutics, Inc. (1)
Australia (1) · France (1) · United States (1)